Fenugreek (Trigonella foenum-graecum)
1. Identity: Botanical Classification, Names, and Common Forms
Fenugreek is an herb extract prepared from the dried seeds of Trigonella foenum-graecum (sicklefruit fenugreek), a plant belonging to the pea family (Fabaceae). It is an aromatic, medicinal plant rich in several important phytochemicals. The species name foenum-graecum literally translates as "Greek hay," suggesting that fenugreek was well known as a forage crop even in the distant past.
Fenugreek is a clover-like herb native to the Mediterranean region, southern Europe, and western Asia. Although believed to have originated in Eastern Europe, fenugreek is now cultivated worldwide, with India being the largest producer, followed by countries such as China, Pakistan, Iran, Afghanistan, Russia, and Australia. It is reported as a cultivated crop in various parts of Europe such as Austria, France, Germany, Greece, Portugal, Russia, Spain, Switzerland, Turkey, and the United Kingdom; Northern Africa including Egypt, Ethiopia, Kenya, Morocco, Sudan, Tanzania, and Tunisia; and West and South Asia including China, India, Iran, Israel, Japan, Lebanon, and Pakistan.
The plant is known by a wide array of vernacular names in different languages and traditions. Other names include Alholva, Bird's Foot, Bockshornklee, Fenogreco, Greek Clover, Greek Hay, Hu Lu Ba, Methi, Trigonella, and Woo Lu Bar.
Common Forms and Preparations
Fenugreek is available in a variety of forms used in culinary, agricultural, and medicinal contexts:
- Whole seeds: Its seeds, which smell and taste like maple syrup, have been used as a spice and a traditional medicine.
- Seed powder: Fenugreek is used topically and in foods as a flavoring agent. The seeds are often ground into a spice known as "methi," which adds a special flavor to curries and other dishes.
- Teas and decoctions: The usual doses used to aid in the management of diabetes and hypercholesterolemia are variable, ranging from 2 to 100 grams daily taken in 2 or 3 divided doses either as capsules or as powder to prepare teas.
- Standardized seed extracts: Proprietary, concentrated preparations enriched in specific bioactive fractions (such as saponins or furostanolic glycosides) are used in clinical trials and dietary supplements.
- Hydrolyzed protein fractions: The herbal source used in some clinical preparations is the hydrolyzed protein of fenugreek seed; dried fenugreek seed is powdered, defatted using hexane, and protein is then extracted by isoelectric precipitation.
- Industrial flavoring: Because of its maple-like flavor, fenugreek has been used as a flavoring agent in foods, beverages, and tobacco. It is also used as a tobacco flavoring, a perfume base, and a source of steroidal sapogenin compounds in the pharmaceutical industry.
2. Traditional and Historical Use
Antiquity and Ancient Egypt
Fenugreek has been used as a medicinal plant for about 6,000 years. It is a remarkable herb with a rich history that stretches back over 4,000 years and has played an important role in traditional medicine systems like Ayurveda, Unani, and Traditional Chinese Medicine.
The first traces of its use date back to Antiquity. The Egyptians, for example, used fenugreek in funeral rituals, notably to embalm corpses, or in cooking to flavor their bread. Its documented appearance in the ancient Egyptian pharmacopeia is notable: fenugreek has been mentioned in the Ebers Papyrus, an Egyptian medical document dating back to 1500 BCE, which referenced it for possible medicinal properties. The plant is traditionally grown in major parts of South Asia, the Middle East, North Africa, and Mediterranean Europe as a spice crop, and as an ingredient of the famous East Indian curries or as part of the traditional curry mix powder of the Indian subcontinent.
Ayurvedic Medicine (India)
In traditional Indian systems of medicine such as Ayurveda, Unani, and Siddha, fenugreek occupies a prominent position due to its diverse therapeutic applications. In India, where the plant is still highly prized, fenugreek has a long tradition of culinary and medicinal use, both in Ayurvedic medicine and in traditional cooking under the name "methi." In Ayurvedic medicine, fenugreek seeds and leaves are renowned for their benefits for digestion and reproductive health.
According to Ayurvedic medicine, fenugreek powder is seen as a rasayana—a substance that regenerates and revitalizes both body and mind. It is also seen as an agni-stimulant, meaning it has the ability to activate the digestive fire, contributing to optimal digestion. Fenugreek seeds are traditionally valued for their carminative, demulcent, expectorant, laxative, and stomachic properties.
In medieval India, herbal physicians recommended fenugreek powder mixed with honey to ease constipation and stimulate digestive fire. Over centuries, it also found its way into Unani and Siddha medicine, where practitioners credited it with promoting healthy lactation and soothing respiratory congestion.
Traditional Chinese Medicine
In Chinese medicine, fenugreek seeds were used as a tonic; in Indian medicine, as a stimulant to lactation; and in many folk medicines as an aid to digestion and treatment of baldness. In TCM, fenugreek is known as "Hu Lu Ba," where it is prescribed for treating kidney weakness, painful menstruation, and male impotence.
Cross-Cultural Uses
In various cultures, fenugreek has been used as a tonic or a laxative; as a remedy for menstrual cramps, menopause symptoms, kidney stones, and other conditions; and to stimulate milk production during breastfeeding. Historically, fenugreek has been used as an important traditional, multipurpose medicinal herb in the Indian Ayurvedic Systems as well as in the treatment of both humans and animal subjects in Traditional Chinese Medicinal Practices and Tibetan Medicinal Practices for several centuries.
Fenugreek has a long history of medical uses in Ayurvedic and Chinese medicine, and has been used for numerous indications, including labor induction, aiding digestion, and as a general tonic to improve metabolism and health. It has been widely used for centuries in traditional medicine for managing various health conditions such as diabetes, inflammation, cancer, hypercholesterolemia, reproductive disorders, and neurodegenerative diseases.
3. Key Constituents and Active Compounds
The plant is rich in bioactive phytochemicals, including flavonoids, alkaloids, coumarins, vitamins, carbohydrates such as galactomannan, saponins, trigonelline, diosgenin, and soluble fibers, which contribute to its pharmacological activities.
Constituents of fenugreek extracts include dietary fibers, mucilages, steroid saponins, flavonoids, trigonelline, and volatile oils. Fenugreek preparations contain high levels of fiber, which may represent 50% of its constituents.
Diosgenin, 4-hydroxyisoleucine, and the fiber component of the plant are the most intensively studied bioactive constituents present in fenugreek. The three are described in detail below.
Diosgenin
The anticancer activity of diosgenin, a steroidal saponin found in fenugreek seeds, has been an area of investigation. The seeds of fenugreek contain about 0.1–0.9% of diosgenin and are extracted commercially. Diosgenin, a steroid sapogenin, is used in the manufacture of birth control pills. Diosgenin is thought to contribute to fenugreek's effects on lipid metabolism; it has been suggested that diosgenin could be a very useful compound to control hypercholesterolemia by both improving the lipid profile and modulating oxidative stress.
4-Hydroxyisoleucine (4-OH-Ile)
Seeds are rich in components like galactomannan, free peptide 4-hydroxyisoleucine, and alkaloids like trigonelline and fenugreekine. These compounds reduce glucose and lipid absorption and enhance metabolism, thus showing anti-diabetic properties. 4-Hydroxyisoleucine is a rare amino acid found in high concentrations in fenugreek seeds and is considered a key contributor to the plant's insulinotropic effects.
Galactomannans (Soluble Dietary Fiber)
Dietary fiber from fenugreek blunts glucose and cholesterol after a meal and regulates the production of cholesterol in the liver, and has potential for widespread use in the food industry because its galactomannan composition has emulsifying and stabilizing properties.
Saponins and Steroidal Sapogenins
Fenugreek glycosides including saponins, sapogenins (e.g., diosgenin), similagenin, savsalpogenin, and yuccagenin are reported to be major components behind the health benefits of fenugreek seeds. A saponin-rich fenugreek extract can generate multi-bioactive extracts that inhibit pancreatic lipase and cholesterol bioaccessibility, potentially leading to a hypocholesterolemic effect.
Flavonoids and Isoflavones
Fenugreek is chemically characterized by the presence of flavone C-glycosides including those derived from apigenin and luteolin, in addition to isoflavones. Five different flavones or their glycosides (apigenin, vicenin-2, vitexin, luteolin, and orientin) and two isoflavones (daidzein and formononetin) have been quantified in fenugreek extracts.
Trigonelline and Alkaloids
Trigonelline, a pyridine alkaloid, is another key constituent. Plant phenolics in fenugreek have potential health benefits mainly due to their antioxidant properties such as reactive oxygen species (ROS) scavenging and inhibition, electrophile scavenging, and metal chelation. They have also been reported to exhibit pharmacological properties such as antitumor, antiviral, antimicrobial, anti-inflammatory, hypotensive, and antioxidant activity.
Phytoestrogens
The presence of phytoestrogens and saponins in fenugreek has been identified as the chemical constituents accountable for the herb's anticancer properties. Phytoestrogens also underlie much of the interest in fenugreek for hormonal and reproductive health applications.
4. Mechanisms of Action
The pancreas, skeletal muscle, liver, adipose tissue, and gut are major tissue targets of fenugreek through which serum markers such as glucose, insulin, and lipids are favorably modulated.
Diosgenin, 4-hydroxyisoleucine, and the fiber component of the plant are the most intensively studied bioactive constituents present in fenugreek. These compounds have been demonstrated to exert beneficial effects on several physiologic markers including glucose tolerance, inflammation, insulin action, liver function, blood lipids, and cardiovascular health.
With respect to glycemic control specifically, fenugreek's galactomannans appear to act through physical mechanisms in the gut: dietary fiber from fenugreek blunts glucose and cholesterol after a meal and regulates the production of cholesterol in the liver. 4-Hydroxyisoleucine is proposed to directly stimulate insulin secretion from pancreatic beta cells, while diosgenin may modulate lipid metabolism at the hepatic level. The lipid- and glucose-lowering effects of fenugreek have been attributed to saponins.
The presence of phytoestrogens and saponins in fenugreek has been identified as the chemical constituents accountable for the herb's anticancer properties. Saponins exhibit a specific inhibitory effect on cell division in tumor cells and possess the capacity to induce apoptotic mechanisms, hence potentially triggering controlled cell death.
Although insights into the molecular mechanisms underlying the favorable effects of fenugreek have been gained, we still do not have definitive evidence establishing its role as a therapeutic agent in metabolic disease.
5. Scientific Evidence by Area of Use
5.1 Blood Glucose and Diabetes
This is the most extensively studied application of fenugreek in human clinical research.
Meta-analyses and systematic reviews: A 2014 meta-analysis of 10 clinical trials found that fenugreek significantly changed fasting blood glucose by −0.96 mmol/L (95% CI: −1.52, −0.40), 2-hour postload glucose by −2.19 mmol/L (95% CI: −3.19, −1.19), and HbA1c by −0.85% (95% CI: −1.49%, −0.22%). The considerable heterogeneity in study results was partly explained by diabetes status and dose: significant effects on fasting and 2-hour glucose were only found for studies that administered medium or high doses in persons with diabetes. Most of the trials were of low methodological quality. Results from clinical trials support beneficial effects of fenugreek seeds on glycemic control in persons with diabetes; however, trials with higher methodology quality using a well-characterized fenugreek preparation of sufficient dose are needed to provide more conclusive evidence.
A subsequent and larger meta-analysis (2024, PMC 11403534) including 19 clinical trials further refined these estimates: that meta-analysis revealed that fenugreek supplementation significantly reduced fasting plasma glucose by 20.32 mg/dL, glycated hemoglobin by 0.54%, and HOMA-IR by 0.36 in patients with type 2 diabetes mellitus. The results indicated significant impacts of fenugreek supplementation on lowering fasting plasma glucose, HbA1c, HOMA-IR, total cholesterol, and LDL-C. Fenugreek supplementation significantly increased the high-density lipoprotein cholesterol concentration in patients with T2DM. However, supplementation with fenugreek did not affect triglycerides, weight, or insulin in patients with T2DM.
A 2023 systematic review (PMC 10531284) searched multiple databases to select RCTs: fenugreek is suggested to be an effective complementary and alternative medicine for controlling blood glucose and lipid profile in individuals with T2DM and prediabetes.
A separate meta-analysis of five clinical trials with a total of 626 diabetic participants showed that fenugreek seeds have significant antidiabetic effects, resulting in a reduction in fasting blood sugar and glycated hemoglobin A1c levels. None of the trials reported any side effects after administering fenugreek seed at various doses, suggesting its safety profile.
Specific clinical trial example: A multicenter, randomized, placebo-controlled, double-blind, add-on clinical study evaluated over a period of 90 consecutive days the efficacy of Fenfuro (daily dosage: 500 mg twice daily) in 154 subjects (male: 108; female: 46; age: 25–60 years) with type 2 diabetes. A clinical trial on humans suffering from T2DM using 15 g of powdered fenugreek seeds with meals reported a reduced rise in blood glucose after the meal. Another similar controlled trial found that taking 2.5 g of fenugreek seed twice a day for 3 months reduced blood glucose levels in people with mild T2DM.
Limitations: The benefits of fenugreek therapy in hypercholesterolemia and diabetes in humans have not been proven in rigorously designed prospective clinical trials. The methods of fenugreek extraction, the preparation of the intact part of fenugreek, dosage, and duration of the treatment have not been standardized, and these differences are speculated to contribute to heterogeneity in results. There is not enough high-quality evidence to determine whether fenugreek is useful for diabetes or menstrual cramps.
5.2 Lipid Profile and Cardiovascular Health
Multiple human clinical studies have investigated fenugreek's effects on serum lipids. Multiple human trials on fenugreek seeds also demonstrate potential efficacy in lowering total cholesterol in people with moderate atherosclerosis or insulin- or non-insulin-dependent diabetes. Two different doses of defatted fenugreek seed powder (25 or 50 g/day) have been shown to significantly lower serum cholesterol after 20 days.
The 2024 meta-analysis of 19 studies (PMC 11403534) reported: significant impacts of fenugreek supplementation on lowering total cholesterol (WMD: 33.10 mg/dL; 95% CI: −64.31 to −1.88) and LDL-cholesterol in patients with T2DM. Fenugreek supplementation significantly increased HDL-cholesterol concentration in patients with T2DM.
The proposed mechanism involves both physical and biochemical pathways: a saponin-rich fenugreek extract can generate multi-bioactive extracts that inhibit pancreatic lipase and cholesterol bioaccessibility, potentially leading to a hypocholesterolemic effect.
Limitations: As with the glycemic data, most lipid trials are small, short-duration, and conducted predominantly in populations with concurrent diabetes. Evidence in primary hypercholesterolemia without metabolic disease is less robust. Results from clinical trials support beneficial effects of fenugreek seeds on glycemic control in persons with diabetes; however, trials with higher methodology quality using a well-characterized fenugreek preparation of sufficient dose are needed to provide more conclusive evidence.
5.3 Lactation and Galactagogue Effect
Fenugreek is one of the most widely used herbal galactagogues globally. Fenugreek seed is recognized for its ability to improve breast milk production.
Animal mechanistic evidence: A galactagogue effect of fenugreek has been demonstrated in a rat model of lactation challenge, foreshadowing its use in women's breastfeeding management.
Cochrane review (2020): Twenty-seven studies compared natural oral galactagogues—including fenugreek—with placebo or no treatment. Three studies involving fennel, fenugreek, moringa, and mixed botanical tea reported infant weight but could not be meta-analysed due to substantial clinical and statistical heterogeneity (I² = 60%, 275 participants, very low-certainty evidence). Subgroup analysis shows we are very uncertain whether fennel or fenugreek improves infant weight. Due to extremely limited, very low certainty evidence, we do not know whether galactagogues have any effect on proportion of mothers who continued breastfeeding at 3, 4, and 6 months. There is low-certainty evidence that pharmacological galactagogues may increase milk volume. There is some evidence from subgroup analyses that natural galactagogues may benefit infant weight and milk volume in mothers with healthy, term infants, but due to substantial heterogeneity of the studies, imprecision of measurements, and incomplete reporting, we are very uncertain about the magnitude of the effect.
Narrative review conclusion: A review of the evidence for the efficacy of popular pharmaceutical and herbal galactagogues revealed a dearth of high-quality clinical trials and mixed results. Health providers face the challenge of prescribing or recommending galactagogues without the benefit of robust evidence. People who breastfeed also take fenugreek to increase milk production, although the evidence there is mixed.
5.4 Testosterone, Libido, and Male Reproductive Health
Interest in fenugreek for male hormonal health has grown, driven largely by its saponin content and purported androgenic effects.
Clinical evidence — testosterone: In one double-blind randomized controlled intervention study, 95 men aged 40–80 years completed a 12-week intervention taking 0 mg (placebo, n=22), 600 mg (n=21), 1,200 mg (n=25), or 1,800 mg (n=27) fenugreek extract with essential nutrients. Samples were collected at weeks 0, 2, 6, and 12. Plasma total testosterone and free testosterone index increased after any dose versus baseline (13.0% and 16.3% respectively), but not versus placebo (9.0%, p=0.122; and 11.3%, p=0.059). Saliva testosterone concentration increased after any dose of the extract versus baseline (31.1%, p=2.3×10⁻⁴) and versus placebo (37.2%, p=0.042).
Pilot RCT — resistance training: The results of a clinical study demonstrated the efficacy of an 8-week treatment of a fenugreek glycoside preparation, offering beneficial effects in terms of repetitions to failure in leg press, free testosterone levels, and serum creatinine as compared with placebo.
Limitation: Many testosterone trials use proprietary, multi-ingredient formulations (e.g., Testofen, Trigozim) that include vitamins and minerals (notably vitamin D, zinc, and magnesium), making it difficult to attribute effects solely to fenugreek. The study aimed to investigate the effect of a food supplement based on a special fenugreek herbal extract supplemented with several vitamins (the most important is probably vitamin D) and two minerals (zinc and magnesium). The overall evidence base for fenugreek as a testosterone-boosting agent in humans is preliminary.
5.5 Menstrual Health, PCOS, and Women's Hormonal Health
Fenugreek is used for reducing blood sugar, improving blood lipids, and increasing testosterone and libido. Fenugreek also shows promise for polycystic ovary syndrome, menopausal symptoms, and dysmenorrhea. In various cultures, it has been used as a remedy for menstrual cramps, menopause symptoms, and kidney stones. Human clinical evidence in these specific areas, however, remains limited, and the NCCIH has noted that there is not enough high-quality evidence to determine whether fenugreek is useful for menstrual cramps.
5.6 Anticancer Properties
The presence of phytoestrogens and saponins in fenugreek has been identified as the chemical constituents accountable for the herb's anticancer properties. Saponins exhibit a specific inhibitory effect on cell division in tumor cells and possess the capacity to induce apoptotic mechanisms, hence potentially triggering controlled cell death. Protodioscin, derived from fenugreek seeds, effectively inhibits the growth of HL60 cells by inducing apoptotic changes.
Preclinical studies have demonstrated that fenugreek extracts and their bioactive constituents can exert cytotoxic effects on HCC cell lines, modulate key signalling pathways, and influence the expression of proteins involved in cell proliferation and apoptosis. Despite these promising findings, translating fenugreek's anticancer potential into clinical practice is hindered by several limitations. The precise molecular mechanisms underlying its effects remain incompletely understood, and the variability in extract composition poses challenges for standardisation and reproducibility.
Evidence rating: Preclinical only. No human clinical trials establishing anticancer efficacy in humans are yet available. All data derive from in vitro cell line studies and animal models.
5.7 Hepatoprotective Activity
Despite being widely used, fenugreek has not been implicated in cases of clinically apparent liver injury and, in prospective studies, has had no effect on serum enzyme levels. In vitro studies have demonstrated hepatoprotective activity of fenugreek extracts in several animal models. Fenugreek supplementation has also been found to protect against chemical-induced liver toxicity in animal studies. These findings remain preclinical.
5.8 Antioxidant Activity
Investigation of its activity in animal models suggested that fenugreek extracts have antioxidant, antihyperlipidemic, and hypoglycemic activities. The extracts of endosperm, husk, and fenugreek seed at about 200 μg concentration exhibited antioxidant activity of 72%, 64%, and 56% respectively by free-radical assay. Human clinical data on antioxidant endpoints are limited.
6. Body Systems Associated with Fenugreek
- Metabolic/Endocrine System: Glycemic regulation, insulin sensitivity, lipid metabolism, type 2 diabetes management.
- Reproductive System: Fenugreek is reported to have a range of health-promoting properties, including stimulating appetite and lactation, enhancing libido, and alleviating menopausal symptoms.
- Gastrointestinal System: Fenugreek seeds were often prescribed to relieve digestive problems, treat constipation, and stimulate appetite. The mucilaginous nature of the seeds was believed to soothe the digestive tract.
- Cardiovascular System: These compounds have been demonstrated to exert beneficial effects on several physiologic markers including glucose tolerance, inflammation, insulin action, liver function, blood lipids, and cardiovascular health.
- Hepatic System: Hepatoprotective effects observed in animal models; the NIH LiverTox database rates fenugreek as unlikely to cause liver injury in humans.
- Musculoskeletal System: Investigated in resistance training contexts for potential effects on muscle performance and body composition.
- Immune/Inflammatory System: Fenugreek's seeds and leaves have been used to treat a variety of ailments, from digestive and respiratory issues to skin problems and inflammation.
7. Dosage Forms and Doses Reported in Studies
There is no single universally established therapeutic dose for fenugreek. Doses vary widely across studies, indications, and preparation types. The following are doses reported in published research:
- Whole seed powder for diabetes/lipids: Doses used to aid in the management of diabetes and hypercholesterolemia are variable, ranging from 2 to 100 grams daily taken in 2 or 3 divided doses either as capsules or as powder to prepare teas. Two different doses of defatted fenugreek seed powder (25 or 50 g/day) significantly lowered serum cholesterol after 20 days. A clinical trial using 15 g of powdered fenugreek seeds with meals reported a reduced rise in blood glucose after the meal. Another controlled trial found that taking 2.5 g of fenugreek seed twice a day for 3 months reduced blood glucose levels in people with mild T2DM.
- Standardized seed extract for diabetes (Fenfuro): A multicenter RCT used 500 mg twice daily of a furostanolic saponin-enriched extract over 90 days in 154 subjects with T2DM.
- Fenugreek dry extract for diabetes: A double-blind RCT was conducted on 54 individuals with T2DM; participants were randomly assigned to receive 3 tablets containing 335 mg of fenugreek seed dry extract daily for 8 weeks or a placebo.
- Fenugreek extract for testosterone (men aged 40–80): A 12-week RCT used doses of 600 mg, 1,200 mg, or 1,800 mg of fenugreek extract daily, in three tablet doses.
- Fenugreek glycoside preparation for resistance training: An 8-week treatment protocol was evaluated in a pilot study for androgenic and anabolic benefits in male subjects during resistance training.
- Subgroup analysis insight: A subgroup analysis of diabetes RCTs revealed that lower fenugreek doses (<10 g/day) resulted in greater reductions in both fasting plasma glucose and HbA1c in comparison to higher doses (≥10 g/day).
8. Safety Considerations and Drug Interactions
General Safety Profile
Side effects of oral fenugreek are minor and include gastrointestinal upset, nausea, diarrhea, bloating, flatulence, and allergic reactions with facial edema, wheezing, dizziness, and shock. Beyond reproductive effects, gastrointestinal disturbances such as diarrhea, flatulence, nausea, and vomiting have been reported in adults, and rare but severe cutaneous adverse reactions, including toxic epidermal necrolysis, have been documented.
Hepatotoxicity Assessment
Despite being widely used, fenugreek has not been implicated in cases of clinically apparent liver injury, and in prospective studies has had no effect on serum enzyme levels. The NIH LiverTox database assigns fenugreek a Likelihood Score of E: unlikely cause of clinically apparent liver injury.
However, a cautionary note is appropriate: overall, fenugreek exhibits a dualistic profile, offering hepatoprotective and antitumor benefits while posing risks of reproductive toxicity, rare hypersensitivity reactions, and potential hepatotoxicity, particularly in susceptible populations or when used concomitantly with drugs. While animal studies generally support a favorable safety profile for fenugreek, there are reports of potential toxic and teratogenic effects, as well as molecular evidence suggesting possible hepatotoxicity and nephrotoxicity at high doses or with prolonged exposure.
Drug Interactions
Because of the high fiber content, estrogenic and coumadin-like effects of fenugreek, it has a potential to cause herb-drug interactions particularly if taken in high doses with antiplatelet drugs and warfarin.
The concurrent use with antidiabetic medications is a clinically relevant consideration: fenugreek's own glucose-lowering activity may augment the hypoglycemic effects of insulin or oral antidiabetic agents, potentially leading to hypoglycemia.
Pregnancy
In humans, fenugreek consumption during pregnancy has been associated with congenital malformations, including hydrocephalus, anencephaly, and spina bifida, as well as increased fetal death rates and morphological abnormalities, raising concerns about its teratogenic potential. These changes have translated into reduced fertility indices and adverse pregnancy outcomes in animal models, suggesting a potential risk for reproductive toxicity.
Allergic Reactions
Fenugreek belongs to the Fabaceae (legume) family. Cross-reactivity with other legumes such as chickpea, peanut, and soy has been documented in the literature, with reports of anaphylactic reactions in individuals with existing legume allergies.
Maple Syrup Odor Phenomenon
A well-documented and benign phenomenon is that fenugreek consumption can cause a maple syrup odor in urine, sweat, and breast milk, attributable to the volatile compound sotolone. This odor can be mistaken for Maple Syrup Urine Disease (MSUD) in infants of breastfeeding mothers consuming fenugreek.
References
Go back